Mostrando 10 resultados de: 23
Publisher
Bionatura(7)
Biotecnologia Aplicada(3)
Pharmaceutics(3)
Centro de Biotecnologia y Biomedicina, Clinical Biotec. Universidad Católica del Oriente (UCO), Univesidad Yachay Tech(2)
BMC Cancer(1)
Área temáticas
Farmacología y terapéutica(13)
Enfermedades(10)
Medicina y salud(5)
Fisiología y materias afines(3)
Ginecología, obstetricia, pediatría, geriatría(3)
A Novel Microencapsulated Bovine Recombinant Interferon Tau Formulation for Luteolysis Modulation in Cattle
ArticleAbstract: Early embryonic loss is a major cause of reproductive inefficiency in cattle, primarily due to premaPalabras claves:interferon tau, luteolysis modulation, MicroencapsulationAutores:Aleikar Vásquez, Camacho F., Felipe Sandoval, Florence Hugues, Garcia-Herreros M.G., Gutiérrez-Reinoso M.A., Ignacio Cabezas, Javiera Yáñez-Torres, Kelly Gancino, Lamazares E., Mena-Ulecia K., Paula Gädicke, Thelvia I. Ramos Gómez, Toledo J.R.Fuentes:scopusMultilayer Nanocarrier for the Codelivery of Interferons: A Promising Strategy for Biocompatible and Long-Acting Antiviral Treatment
ArticleAbstract: Background: Interferons (IFNs) are cytokines involved in the immune response with a synergistic reguPalabras claves:Antiproliferative, antiviral, Core-shell, Drug delivery system, Immunoregulation, interferons, nanoencapsulation, toxicityAutores:Altamirano C., Debut Alexis, Felipe Sandoval, Florence Hugues, Gómez-Gaete C., Hortensia Rodriguez Cabrera, Ignacio Cabezas, Lamazares E., Leandro Santiago-Padilla, marbel torres arias, Montesino R., Parra N.C., Ramos O.S., Santiago Nelson Vispo, Sarah Martin-Solano, Thelvia I. Ramos Gómez, Toledo J.R., Viana Manrique-Suárez, Villacis-Aguirre C.A.Fuentes:scopusFrom Genetic Engineering to Preclinical Safety: A Study on Recombinant Human Interferons
ArticleAbstract: There is a critical gap in the preclinical research of recombinant human interferons (rhIFNα-2b andPalabras claves:animal model, Antiproliferative, antiviral, bioactivity, Immunomodulatory, interferon alpha, Interferon gamma, Preclinical, Recombinant, toxicityAutores:Cristy N. Culqui-Tapia, Felipe Sandoval, Ignacio Cabezas, Lamazares E., Mansilla R., María A. Contreras, Parra N.C., Sanchez O., Santiago Nelson Vispo, Sarah Martin-Solano, Sergio Donoso-Erch, Thelvia I. Ramos Gómez, Viana Manrique-Suárez, Villacis-Aguirre C.A.Fuentes:scopusThe Hitchhiker’s Guide to Human Therapeutic Nanoparticle Development
ReviewAbstract: Nanomedicine plays an essential role in developing new therapies through novel drug delivery systemsPalabras claves:clinical trials, Immunotoxicity, nanomedicine, Nanoparticles, pharmacokinetics, Preclinical, Regulatory aspectsAutores:Altamirano C., Katherine V. López-Aguilar, Santiago Nelson Vispo, Thelvia I. Ramos Gómez, Toledo J.R., Villacis-Aguirre C.A.Fuentes:scopusCIGB-300, a novel proapoptotic peptide that impairs the CK2 phosphorylation and exhibits anticancer properties both in vitro and in vivo
ArticleAbstract: Protein Kinase CK2 is a serine-threonine kinase frequently deregulated in many human tumors. Here, wPalabras claves:apoptosis, Cancer targeted therapy, Casein kinase 2Autores:Acevedo B.E., Alonso D.F., Ariosa J., Bacardí D.M., Baladron I., Besada-Pérez V., Betancourt L., Castellanos L.R., Cosme K., Cruz M., Díaz A., Falcón-Cama V., Farina H., Garay H.E., Gil J., Gómez D., Gómez R., González L.J., Hernández I., Herrera L., López C., López-Mola E., López-Saura P.A., Marcelo J.L., Mendoza O., Perea-Rodríguez S.E., Perera Y., Puchades Y., Reyes O., Rodriguez A., Sánchez A., Santana A., Serrano J.M., Sigman H., Silva R., Solares M., Thelvia I. Ramos Gómez, Valenzuela-Silva C.M.Fuentes:googlescopusActive immunotherapy in lung cancer, new therapeutic options
OtherAbstract:Palabras claves:Autores:Thelvia I. Ramos GómezFuentes:scopusAdditives and protein-DNA combinations modulate the humoral immune response elicited by a hepatitis C virus core-encoding plasmid in mice
ArticleAbstract: Humoral and cellular immune responses are currently induced against hepatitis C virus (HCV) core folPalabras claves:Core, DNA immunization, Hepatitis C virusAutores:Alvarez-Lajonchere L., Dueñas-Carrera S., Morales J., Pichardo D., Thelvia I. Ramos Gómez, Viña A.Fuentes:scopusAdjuvant interferon gamma in patients with pulmonary atypical Mycobacteriosis: A randomized, double-blind, placebo-controlled study
ArticleAbstract: Background: High antibiotic resistance is described in atypical Mycobacteriosis, mainly by MycobactePalabras claves:Autores:Bello-Rivero I., Fernández-Olivera N., García-García I., González-Méndez L., Jiménez-Madrigal G., López-Saura P.A., Martínez-Sánchez G., Milanés-Virelles M.T., Rodríguez-Acosta C., Sánchez-de la Osa R.B., Santos-Herrera Y., Thelvia I. Ramos Gómez, Valdés-Quintana M., Valenzuela-Silva C.M.Fuentes:googlescopusAdvances in Clinical Research in Ecuador
ArticleAbstract: Ecuador is undergoing a process of clinical research development and strengthening. At the turn of tPalabras claves:clinical research, clinical trials, Economic development, ECUADOR, PharmaceuticalAutores:Castro K.A., Luis Santiago Escalante, Santiago Nelson Vispo, Thelvia I. Ramos GómezFuentes:scopusCase report of post-surgery anterior cruciate ligament surgery
ArticleAbstract: An anterior cruciate ligament (ACL) is the most prevalent knee injury in athletes. Advances in surgiPalabras claves:Anterior cruciate ligament, functional rehabilitation, grafting, Movement, Muscle strength, ProprioceptionAutores:Clara Gualotuña, Thelvia I. Ramos GómezFuentes:scopus